107 related articles for article (PubMed ID: 12459396)
1. In regard to Donaldson et al: results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma-a report from the IRSG. IJROBP 2001;51:718-728.
Timmerman RD; Mendonca M
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1579-80; author reply 1580. PubMed ID: 12459396
[No Abstract] [Full Text] [Related]
2. Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma--a report from the IRSG.
Donaldson SS; Meza J; Breneman JC; Crist WM; Laurie F; Qualman SJ; Wharam M;
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):718-28. PubMed ID: 11597814
[TBL] [Abstract][Full Text] [Related]
3. Hyperfractionated radiation in children with rhabdomyosarcoma--results of an Intergroup Rhabdomyosarcoma Pilot Study.
Donaldson SS; Asmar L; Breneman J; Fryer C; Glicksman AS; Laurie F; Wharam M; Gehan EA
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):903-11. PubMed ID: 7607964
[TBL] [Abstract][Full Text] [Related]
4. Treatment of orbital rhabdomyosarcoma: survival and late effects of treatment--results of an international workshop.
Oberlin O; Rey A; Anderson J; Carli M; Raney RB; Treuner J; Stevens MC;
J Clin Oncol; 2001 Jan; 19(1):197-204. PubMed ID: 11134213
[TBL] [Abstract][Full Text] [Related]
5. A phase II trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma.
Regine WF; Fontanesi J; Kumar P; Zeitzer K; Greenwald C; Bowman L; Shapiro DN; Rao BN; Kun LE
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):799-805. PubMed ID: 7860391
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy oncology: in regard to Fu et al., IJROBP 2000;48:7-16.
Logie MB
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1148. PubMed ID: 11958925
[No Abstract] [Full Text] [Related]
7. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard-fractionation radiotherapy for head-and-neck squamous cell carcinomas: first report of RTOG 9003: in regard to Fu et al. IJROBP 2000;48:7-16. Actuarial estimates of late normal-tissue effects...now!
Dubben HH; Beck-Bornholdt HP
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):563. PubMed ID: 11579925
[No Abstract] [Full Text] [Related]
8. The Intergroup Rhabdomyosarcoma Study-I. A final report.
Maurer HM; Beltangady M; Gehan EA; Crist W; Hammond D; Hays DM; Heyn R; Lawrence W; Newton W; Ortega J
Cancer; 1988 Jan; 61(2):209-20. PubMed ID: 3275486
[TBL] [Abstract][Full Text] [Related]
9. Influence of radiation therapy parameters on outcome in children treated with radiation therapy for localized parameningeal rhabdomyosarcoma in Intergroup Rhabdomyosarcoma Study Group trials II through IV.
Michalski JM; Meza J; Breneman JC; Wolden SL; Laurie F; Jodoin M; Raney B; Wharam MD; Donaldson SS
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1027-38. PubMed ID: 15234036
[TBL] [Abstract][Full Text] [Related]
10. In regard to Staar et al.: Intensified hyperfractionated accelerated radiotherapy limits the additional benefits of simultaneous chemotherapy-results of a multicentric randomized German trial in advanced head-and-neck cancer. IJROBP 2001;50:1161-1171.
Grabenbauer GG; Sauer R
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):300. PubMed ID: 12183004
[No Abstract] [Full Text] [Related]
11. Evaluation of intensified chemotherapy in children with advanced rhabdomyosarcoma (clinical groups III and IV). The Intergroup Rhabdomyosarcoma Study (IRS) Committee of the Cancer and Leukemia Group B Children's Cancer Study Group, Southwest Oncology Group.
Raney RB; Gehan EA; Maurer HM; Newton WA; Ragab AH; Ruymann FB; Sutow WW; Tefft M
Cancer Clin Trials; 1979; 2(1):19-28. PubMed ID: 391431
[TBL] [Abstract][Full Text] [Related]
12. In regard to Denham et al., is it time for a new formalism to categorize normal tissue radiation injury? IJROBP 2001;50:1105-1106.
Seymour CB; Moriarty M; Mothersill C
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1147-8; author reply 1148. PubMed ID: 11958922
[No Abstract] [Full Text] [Related]
13. The Intergroup Rhabdomyosarcoma Study-II.
Maurer HM; Gehan EA; Beltangady M; Crist W; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J
Cancer; 1993 Mar; 71(5):1904-22. PubMed ID: 8448756
[TBL] [Abstract][Full Text] [Related]
14. Role of radiation therapy in parameningeal rhabdomyosarcoma.
Paulino AC
Cancer Invest; 1999; 17(3):223-30. PubMed ID: 10099663
[TBL] [Abstract][Full Text] [Related]
15. [Childhood rhabdomyosarcoma].
Morikawa Y
Nihon Geka Gakkai Zasshi; 2005 Jul; 106(7):431-6. PubMed ID: 16045187
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy combined with systemic chemotherapy of rhabdomyosarcoma in children: local control in patients enrolled in the Intergroup Rhabdomyosarcoma Study.
Tefft M; Lindberg RD; Gehan EA
Natl Cancer Inst Monogr; 1981 Apr; (56):75-81. PubMed ID: 7029298
[TBL] [Abstract][Full Text] [Related]
17. Delayed-accelerated hyperfractionated radiation therapy for advanced-stage or high-risk rhabdomyosarcoma.
Merchant TE
Med Pediatr Oncol; 1997 Jul; 29(1):45-50. PubMed ID: 9142206
[TBL] [Abstract][Full Text] [Related]
18. Local therapy is critical in localised pelvic rhabdomyosarcoma: experience of the International Society of Pediatric Oncology Malignant Mesenchymal Tumor (SIOP-MMT) committee.
Réguerre Y; Martelli H; Rey A; Rogers T; Gaze M; Ben Arush MW; Devalck C; Oberlin O; Stevens M; Orbach D
Eur J Cancer; 2012 Sep; 48(13):2020-7. PubMed ID: 22154650
[TBL] [Abstract][Full Text] [Related]
19. The Third Intergroup Rhabdomyosarcoma Study.
Crist W; Gehan EA; Ragab AH; Dickman PS; Donaldson SS; Fryer C; Hammond D; Hays DM; Herrmann J; Heyn R
J Clin Oncol; 1995 Mar; 13(3):610-30. PubMed ID: 7884423
[TBL] [Abstract][Full Text] [Related]
20. Very accelerated fractionation--in response to Dr. C. C. Wang, IJROBP 32:889-890; 1995.
Bourhis J; Wibault P; Eschwege F
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1266-7. PubMed ID: 7607957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
